Stanford University
Palo Alto, California, 94305, United States
NCT Number: NCT06567561
Investigators hope to learn about potential dietary intervention strategies (specifically a whole-food, plant-based diet) that may help lower cancer markers in firefighters.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Palo Alto, California, 94305, United States
The purpose of the San Francisco (SF) Firefighter's Diet Study is to determine if a diet low in processed foods, mostly plant-based, with added fermented foods, can lower the risk of cancer in firefighters. We will assess this by randomly assigning SF firefighters to either a whole-food, plant-based diet or their usual firehouse meals. Participants will be followed for 12 weeks.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Whole foods, predominantly plant-based diet, with the addition of fish, eggs, and fermented dairy.
Usual firehouse meals.
Time frame: Baseline and 8 weeks
Difference in the 8-week change from baseline in IL-6 between the whole-food plant-based vs. usual diet groups.
Time frame: Baseline and 8 weeks
Difference in the 8-week change from baseline in Glyc a between the whole-food plant-based vs. usual diet groups.
Time frame: Baseline and 8 weeks
Difference in the 8-week change from baseline in C-Reactive Protein (CRP) between the whole-food plant-based vs. usual diet groups.
Time frame: Baseline and 8 weeks
Difference in the 8-week change from baseline in Interleukin-10 (IL-10) between the whole-food plant-based vs. usual diet groups.
Time frame: Baseline and 8 weeks
Difference in the 8-week change from baseline in Tumor Necrosis Factor-alpha (TNF-alpha) between the whole-food plant-based vs. usual diet groups.
Time frame: Baseline and 8 weeks
Difference in the 8-week change from baseline in a panel of cytokines and inflammatory proteins using the NUcleic acid Linked Immuno-Sandwich Assay (NULISA™) between the whole-food plant-based vs. usual diet groups.
Time frame: Baseline and 8 weeks
Difference in the 8-week change from baseline in Calprotectin between the whole-food plant-based vs. usual diet groups.
Time frame: Baseline and 8 weeks
Difference in the 8-week change from baseline in 8-hydroxy-2'-deoxyguanosine (8-OH-dG) between the whole-food plant-based vs. usual diet groups.
Time frame: Baseline and 8 weeks
Difference in the 8-week change from baseline in Lipid Peroxidation between the whole-food plant-based vs. usual diet groups, using the Thiobarbituric acid-reactive substance (TBARS) assay.
Time frame: Baseline and 8 weeks
Difference in the 8-week change from baseline in Protein Carbonyl (a measure of protein oxidation) between the whole-food plant-based vs. usual diet groups, using the enzyme-linked immunosorbent assay (ELISA).
Time frame: Baseline and 8 weeks
Difference in the 8-week change from baseline in Fasting Glucose between the whole-food plant-based vs. usual diet groups.
Time frame: Baseline and 8 weeks
Difference in the 8-week change from baseline in Fasting Insulin between the whole-food plant-based vs. usual diet groups.
Time frame: Baseline and 8 weeks
Difference in the 8-week change from baseline in Low-Density-Lipoprotein Cholesterol (LDL) between the whole-food plant-based vs. usual diet groups.
Time frame: Baseline and 8 weeks
Difference in the 8-week change from baseline in High-Density-Lipoprotein Cholesterol (HDL) between the whole-food plant-based vs. usual diet groups.
Time frame: Baseline and 8 weeks
Difference in the 8-week change from baseline in Triglycerides (TRGs) between the whole-food plant-based vs. usual diet groups.
Time frame: Baseline and 8 weeks
Difference in the 8-week change from baseline in Telomeres between the whole-food plant-based vs. usual diet groups.
Time frame: Baseline and 8 weeks
Difference in the 8-week change from baseline in Epigenetic Age between the whole-food plant-based vs. usual diet groups, assessed by Epigenetic Clocks.
Time frame: Baseline and 8 weeks
Difference in the 8-week change from baseline in Gut Microbiome Composition between the whole-food plant-based vs. usual diet groups, assessed by Metagenomic Sequencing.
Time frame: Baseline and 8 weeks
Difference in the 8-week change from baseline in Gut Microbiome Composition between the whole-food plant-based vs. usual diet groups, assessed by assessed by Targeted and Untargeted Metabolomics
Time frame: Baseline and 8 weeks
Difference in the 8-week change from baseline in 4-hydroxynonenal (HNE) between the whole-food plant-based vs. usual diet groups.
Time frame: Baseline and 8 weeks
Difference in the 8-week change from baseline in body composition between the whole-food plant-based vs. usual diet groups, as assessed by dual energy x-ray absorptiometry scan (DEXA) scans.
Time frame: Baseline and 8 weeks
Difference in the 8-week change from baseline in weight between the whole-food plant-based vs. usual diet groups.
Time frame: Baseline and 8 weeks
Difference in the 8-week change from baseline in systolic blood pressure between the whole-food plant-based vs. usual diet groups.
Time frame: Baseline and 8 weeks
Difference in the 8-week change from baseline in diastolic blood pressure between the whole-food plant-based vs. usual diet groups.
Stanford University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01143519
Cancer, Cardiomyopathies
Research Triangle Park, North Carolina, United States
View Trial DetailsNCT01761877
Breast Diseases, Breast Neoplasms
Tucson, Arizona, United States
View Trial DetailsNCT02539355
Body Weight, Cancer
Seattle, Washington, United States
View Trial DetailsNCT01180907
Cancer, Inflammation
Los Angeles, California, United States
View Trial Details